Expression of cell surface receptors, CD44, CD74, CXCR4, LRP1, and NCL was determined by flow cytometry in CD14+ CD16+ and CD14− CD16+ myeloid cells, as well as GD2+ NB cells. The gene discussed is LRP1; the disease is neuroblastoma.